Table 1.
Number and proportion of Atlantic salmon used per group and treatment for the first and second trials. In the first trial, post-smolt fish were challenged with the LF-89 genogroup of P. salmonis, while in the second trial, adult fish were challenged with the EM-90 genogroup of P. salmonis and with the sea lice C. rogercresseyi.
| Group | Treatments | First Trial | Second Trial |
|---|---|---|---|
| Cohabitant | Vaccinated (HV) | 496 | 83 |
| Unvaccinated (HUV) | 335 | 96 | |
| Total cohabitant (H) | 831 | 179 | |
| HUV/H | 42% | 53% | |
| Trojan | Total Trojans (T) | 2903 | 183 |
| T/(H + T) | 77% | 41% | |
| Control | Vaccinated (CV) | 506 | 38 |
| Unvaccinated (CUV) | 727 | 42 | |
| Total control (C) | 1233 | 80 | |
| Total fish (H + T + C) | 4987 | 442 |